Design
Review
Authors
Loading...
Does not yet support clinical targeting of brown/beige fat modulators; leaves open their therapeutic potential in age-related metabolic disorders.
Key points are not available for this paper at this time.
Elisabetta Mueller (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: